Purple Biotech (PPBT) Other Non-Current Assets (2018 - 2026)

Purple Biotech (PPBT) has 9 years of Other Non-Current Assets data on file, last reported at $7.6 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 72.8% year-over-year to $7.6 million in Q1 2026; TTM through Mar 2026 was $7.6 million, a 72.8% decrease from a year earlier, with the FY2025 full-year figure at $7.7 million, up 128333.33% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $7.6 million, down from $7.7 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for PPBT reached as high as $28.7 million in Q1 2023 and fell as low as $6000.0 in Q4 2023.
• Historically, Other Non-Current Assets has averaged $18.3 million across 5 years, with a median of $26.2 million in 2022.
• Across the five-year window, Other Non-Current Assets plunged 93.75% in 2022 and surged 128333.33% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $10000.0 in 2022, then sank by 40.0% to $6000.0 in 2023, then changed by 0.0% to $6000.0 in 2024, then jumped by 128333.33% to $7.7 million in 2025, then fell by 0.88% to $7.6 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $7.6 million in Q1 2026, $7.7 million in Q4 2025, and $28.1 million in Q2 2025.